Aa. Sneddon et al., Amelioration of denervation-induced atrophy by clenbuterol is associated with increased PKC-alpha activity, AM J P-ENDO, 279(1), 2000, pp. E188-E195
Citations number
35
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Rat soleus muscle was denervated for 3 or 7 days, and total membrane protei
n kinase C (PKC) activity and translocation and immunocytochemical localiza
tion of PKC isoforms were examined. Dietary administration of clenbuterol c
oncomitant with denervation ameliorated the atrophic response and was assoc
iated with increased membrane PKC activity at both 3 (140%) and 7 (190%) da
ys. Of the five PKC isoforms (alpha, epsilon, theta, zeta, and mu) detected
in soleus muscle by Western immunoblotting, clenbuterol treatment affected
only the PKC-alpha and PKC-theta forms. PKC-alpha was translocated to the
membrane fraction upon denervation, and the presence of clenbuterol increas
ed membrane-bound PKC-alpha and active PKC-alpha as assayed by Ser(657) pho
sphorylation. PKC-theta protein was downregulated upon denervation, and tre
atment with clenbuterol further decreased both cytosolic and membrane level
s. Immunolocalization of PKC-theta showed differences for regulatory and ca
talytic domains, with the latter showing fast-fiber type specificity. The r
esults suggest potential roles of PKC-alpha and PKC-theta in the mechanism
of action of clenbuterol in alleviating denervation-induced atrophy.